Literature DB >> 27321101

Hepcidin and iron status in pregnant women and full-term newborns in first days of life.

Beata Kulik-Rechberger1, Artur Kościesza, Elżbieta Szponar, Justyna Domosud.   

Abstract

OBJECTIVES: The amount of iron is regulated by hepcidin. The aim of the study was to assess hepcidin concentrations in healthy pregnant women before delivery, in cord blood, and in 3-day-old newborns in relation to maternal and neonatal iron status.
MATERIAL AND METHODS: The study group consisted of 44 mother-newborn pairs. Serum concentrations of hepcidin, ferritin, and transferrin receptor (sTfR) were assessed.
RESULTS: Maternal hepcidin was significantly lower than cord blood (p < 0.001), and full-term newborn values (p < 0.001). Mothers also had the lowest ferritin and sTfR concentrations. The highest concentration of hepcidin was observed in the newborns. They had lower sTfR and higher ferritin concentrations than in cord blood (p < 0.001). Maternal ferritin correlated negatively with sTfR (R = -0.50 p = 0.005), and positively with hepcidin (R = 0.41; p = 0.005). There were no correlations between hepcidin and ferritin or sTfR concentrations in cord blood, nor between hepcidin and ferritin or sTfR concentrations in the newborns. Moreover, there were no correlations between maternal and cord blood or neonatal blood hepcidin, nor between maternal hepcidin and infant iron status. There were also no correlations between hepcidin in cord blood and hepcidin or parameters of the iron status in the children.
CONCLUSIONS: It may be assumed that a relatively low concentration of hepcidin in women in late pregnancy facilitates their iron accumulation. Higher levels of hepcidin in full-term newborns than in their mothers may be the result of a relatively high level of iron from the stored supplies. Neonatal iron status was independently associated with either maternal or cord blood hepcidin.

Entities:  

Keywords:  hepcidin; newborn; pregnancy

Mesh:

Substances:

Year:  2016        PMID: 27321101     DOI: 10.17772/gp/62202

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  6 in total

1.  A systematic review and meta-analysis of the correlation between maternal and neonatal iron status and haematologic indices.

Authors:  Omolara B Sanni; Thane Chambers; Jia Hang Li; Stewart Rowe; Andrew G Woodman; Maria B Ospina; Stephane L Bourque
Journal:  EClinicalMedicine       Date:  2020-10-08

2.  Serum hepcidin and iron status parameters in pregnant women and the association with adverse maternal and fetal outcomes: a study protocol for a prospective cohort study.

Authors:  Gabriela Amstad Bencaiova; Deborah Ruth Vogt; Irene Hoesli
Journal:  BMJ Open       Date:  2019-11-06       Impact factor: 2.692

3.  Systemic inflammatory status - a bridge between gestational weight gain and neonatal outcomes (STROBE-compliant article).

Authors:  Cosmin Rugină; Cristina Oana Mărginean; Lorena Elena Meliţ; Adina Huţanu; Dana Valentina Ghiga; Viviana Modi; Claudiu Mărginean
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

4.  Hepcidin, Serum Iron, and Transferrin Saturation in Full-Term and Premature Infants during the First Month of Life: A State-of-the-Art Review of Existing Evidence in Humans.

Authors:  James H Cross; Andrew M Prentice; Carla Cerami
Journal:  Curr Dev Nutr       Date:  2020-06-17

5.  Iron stores at birth in a full-term normal birth weight birth cohort with a low level of inflammation.

Authors:  Joy Y Zhang; Jing Wang; Ru Wei; Gendie E Lash; Qinsheng Lu; Meizhen Tan
Journal:  Biosci Rep       Date:  2020-12-23       Impact factor: 3.840

Review 6.  Maternal Iron Status in Pregnancy and Child Health Outcomes after Birth: A Systematic Review and Meta-Analysis.

Authors:  Hugo G Quezada-Pinedo; Florian Cassel; Liesbeth Duijts; Martina U Muckenthaler; Max Gassmann; Vincent W V Jaddoe; Irwin K M Reiss; Marijn J Vermeulen
Journal:  Nutrients       Date:  2021-06-28       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.